These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29694724)

  • 1. Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies.
    Puchades Renau L; Berenguer M
    Hemodial Int; 2018 Apr; 22 Suppl 1():S8-S21. PubMed ID: 29694724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic manifestations of HCV: the role of direct acting antivirals.
    Polo ML; Laufer N
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):737-746. PubMed ID: 28696154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
    Mendizabal M; Reddy KR
    J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals.
    Debes JD; de Knegt RJ; Boonstra A
    Transplantation; 2017 May; 101(5):910-915. PubMed ID: 28045877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection.
    Weisberg IS; Jacobson IM
    Expert Opin Pharmacother; 2017 Apr; 18(5):535-543. PubMed ID: 28092171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C: a systematic review.
    Kohli A; Shaffer A; Sherman A; Kottilil S
    JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.
    Sawinski D; Bloom RD
    Transplantation; 2015 Dec; 99(12):2458-66. PubMed ID: 26214816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of hepatitis C virus infection treatment in kidney transplant candidates.
    Cohen-Bucay A; Francis JM; Gordon CE
    Hemodial Int; 2018 Apr; 22 Suppl 1():S61-S70. PubMed ID: 29694723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents.
    Reddy YNV; Nunes D; Chitalia V; Gordon CE; Francis JM
    Hemodial Int; 2018 Apr; 22 Suppl 1(Suppl 1):S53-S60. PubMed ID: 29694721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of disease manifestations after HCV eradication.
    van der Meer AJ; Berenguer M
    J Hepatol; 2016 Oct; 65(1 Suppl):S95-S108. PubMed ID: 27641991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C-related cirrhosis. Current status.
    Conde I; Vinaixa C; Berenguer M
    Med Clin (Barc); 2017 Jan; 148(2):78-85. PubMed ID: 27855947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
    Kim SM; Song IH
    Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beclabuvir for the treatment of hepatitis C.
    Gentile I; Zappulo E; Buonomo AR; Maraolo AE; Borgia G
    Expert Opin Investig Drugs; 2015; 24(8):1111-21. PubMed ID: 26156630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.